ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,235Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 783

$1.46M Total Retail Price of All Prescriptions

Rank: 10 out of 783

881 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 881 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 881 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 22,240 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
AMLODIPINE BESYLATE 961 919 1 5
FUROSEMIDE 929 868 2 7
LEVOTHYROXINE SODIUM 785 682 3 1
SIMVASTATIN 748 652 4 3
OMEPRAZOLE 661 608 5 6
HYDROCODONE-ACETAMINOPHEN 647 542 S3 6 2
POTASSIUM CHLORIDE 640 610 7 16
WARFARIN SODIUM 545 533 8 10
LISINOPRIL 446 374 9 4
PRAVASTATIN SODIUM 422 384 10 14
CITALOPRAM HBR 396 361 11 19
METOPROLOL TARTRATE 393 368 12 9
GABAPENTIN 379 324 13 15
PREDNISONE 375 315 14 36
LOSARTAN POTASSIUM 359 333 15 18
ATENOLOL 337 320 16 17
ATORVASTATIN CALCIUM 334 298 17 11
METFORMIN HCL 329 279 18 8
DONEPEZIL HCL 320 305 19 24
HYDROCHLOROTHIAZIDE 303 287 20 12
CEPHALEXIN 302 263 21 70
PANTOPRAZOLE SODIUM 288 278 22 30
POLYETHYLENE GLYCOL 3350 255 218 23 43
SERTRALINE HCL 251 229 24 22
CARVEDILOL 245 214 25 21
TRAMADOL HCL 233 215 26 20
TAMSULOSIN HCL 231 204 27 26
METOPROLOL SUCCINATE 220 193 28 13
RISPERIDONE 203 170 29 67
ADVAIR DISKUS 203 163 29 50
CLOPIDOGREL 201 175 31 29
ZOLPIDEM TARTRATE 201 166 31 23
KLOR-CON M20 199 191 33 48
ISOSORBIDE MONONITRATE ER 198 162 34 40
LANTUS 193 157 35 38
AZITHROMYCIN 191 180 36 41
RANITIDINE HCL 177 145 37 44
NAMENDA 172 166 38 32
JANUVIA 166 158 39 73
NEXIUM 162 140 40 28
FAMOTIDINE 160 139 41 55
GLIPIZIDE 160 146 41 71
LEVOFLOXACIN 152 121 43 75
NOVOLOG 148 130 44 81
CARBIDOPA-LEVODOPA 147 147 45 88
ALENDRONATE SODIUM 139 139 46 25
DIGOXIN 136 134 47 61
ROPINIROLE HCL 132 128 48 74
CYMBALTA 130 116 49 35
DIVALPROEX SODIUM 129 77 50 72
LOSARTAN-HYDROCHLOROTHIAZIDE 129 127 50 53
GLIPIZIDE ER 126 96 52 84
PLAVIX 124 112 53 51
CIPROFLOXACIN HCL 123 90 54 62
QUETIAPINE FUMARATE 122 121 55 79
KLOR-CON 10 119 97 56 102
FENTANYL 117 113 S2 57 65
ALBUTEROL SULFATE 116 83 58 136
ESCITALOPRAM OXALATE 115 103 59 54
SPIRIVA 115 79 59 59
TRAZODONE HCL 111 78 61 39
SULFAMETHOXAZOLE-TRIMETHOPRIM 111 104 61 95
DIOVAN 103 101 63 49
LEVETIRACETAM 100 89 64 89
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 93 64 33
TRIAMTERENE-HCTZ 96 96 66 42
PROAIR HFA 96 64 66 56
GLYBURIDE 93 93 R 68 111
FLUOXETINE HCL 87 56 69 45
CYCLOBENZAPRINE HCL 85 74 R 70 63
SPIRONOLACTONE 84 77 71 57
OXYBUTYNIN CHLORIDE ER 80 70 72 117
CLONIDINE HCL 79 54 73 60
OXYBUTYNIN CHLORIDE 79 75 73 96
SINGULAIR 77 70 75 90
CRESTOR 77 58 75 27
MIRTAZAPINE 76 75 77 52
INSULIN SYRINGE 76 49 77 82
HUMALOG 72 37 79 101
ALLOPURINOL 71 61 80 31
HYDRALAZINE HCL 70 70 81 78
DILTIAZEM ER 68 55 82 153
IPRATROPIUM-ALBUTEROL 68 68 82 110
CLOZAPINE 65 17 84 222
FINASTERIDE 64 64 85 127
BENAZEPRIL HCL 64 59 85 85
DILTIAZEM 24HR CD 64 64 85 118
LANTUS SOLOSTAR 62 44 88 91
CELEBREX 62 61 88 93
AMIODARONE HCL 61 61 90 175
OXYCODONE-ACETAMINOPHEN 61 41 S2 90 76
DIVALPROEX SODIUM ER 60 42 92 180
LEVEMIR FLEXPEN 60 49 92 155
METHADONE HCL 60 58 S2 92 193
ZETIA 58 42 95 80
LOVASTATIN 58 57 95 58
SYMBICORT 57 52 97 157
PEN NEEDLE 57 49 97 103
BYSTOLIC 57 57 97 99
NITROGLYCERIN PATCH 57 57 97 187
FLUTICASONE PROPIONATE 57 54 97 46
PROMETHAZINE HCL 56 42 R 102 97
DILTIAZEM 24HR ER 56 55 102 122
ABILIFY 55 52 104 148
MELOXICAM 55 40 104 37
NOVOLOG FLEXPEN 55 51 104 142
METOLAZONE 55 55 104 186
AMITIZA 54 40 108 282
PAROXETINE HCL 54 43 108 69
GENERLAC 53 41 110 246
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 12, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.